Cargando…

Tough decisions on essential medicines in 2015

Detalles Bibliográficos
Autores principales:	Magrini, Nicola, Robertson, Jane, Forte, Gilles, Cappello, Bernadette, Moja, Lorenzo P, de Joncheere, Kees, Kieny, Marie-Paule
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Health Organization 2015
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431566/ https://www.ncbi.nlm.nih.gov/pubmed/26229193 http://dx.doi.org/10.2471/BLT.15.154385

Ejemplares similares

The 19th EML as a global standard: an innovative approach or just an opportunity for new and effective medicines?
por: Magrini, Nicola, et al.
Publicado: (2015)

Patent pooling to increase access to essential medicines
por: Burrone, Esteban, et al.
Publicado: (2019)

The “Square Box”: Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines
por: Cappello, Bernadette, et al.
Publicado: (2020)

Medicines for cancers in children: The WHO model for selection of essential medicines
por: Robertson, Jane, et al.
Publicado: (2015)

Medicines availability for non-communicable diseases: the case for standardized monitoring
por: Robertson, Jane, et al.
Publicado: (2015)

Erratum to: Medicines availability for non-communicable diseases: the case for standardized monitoring
por: Robertson, Jane, et al.
Publicado: (2015)

Essential medicines for cancer: WHO recommendations and national priorities
por: Robertson, Jane, et al.
Publicado: (2016)

Guideline recommendations and antimicrobial resistance: the need for a change
por: Elias, Christelle, et al.
Publicado: (2017)

Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO
por: Piggott, Thomas, et al.
Publicado: (2022)

Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool
por: Walsh, Jennifer, et al.
Publicado: (2022)

Honouring the value of people in public health: a different kind of p-value
por: Bishai, David, et al.
Publicado: (2015)

Cost–effectiveness thresholds: pros and cons
por: Bertram, Melanie Y, et al.
Publicado: (2016)

Back to the ‘essence’ of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines
por: Eniu, Alexandru, et al.
Publicado: (2016)

Tough decisions
por: Jankharia, Bhavin
Publicado: (2011)

The importance of fracture toughness in ultrafine and nanocrystalline bulk materials
por: Pippan, R., et al.
Publicado: (2016)

Easy in, tough out: the dam of health-care racism
por: Choo, Esther
Publicado: (2021)

Response: Getting Tough with Smoking
por: Covey, Lirio S., et al.
Publicado: (2003)

Systematic Analysis of Evidence and Sound Expert Assessment: Two Enablers of Evidence‐Based Decision‐Making in Health
por: Kieny, Marie Paule, et al.
Publicado: (2018)

Comparison of essential medicines lists in 137 countries
por: Persaud, Nav, et al.
Publicado: (2019)

Essentials of Neonatal–Perinatal Medicine Fellowship: careers in Neonatal–Perinatal Medicine
por: Trzaski, Jennifer M., et al.
Publicado: (2022)

Fostering local production of essential medicines in Nigeria
por: Fatokun, Omotayo
Publicado: (2020)

Supply chain transparency and the availability of essential medicines
por: Årdal, Christine, et al.
Publicado: (2021)

Strengthening health systems for universal health coverage and sustainable development
por: Kieny, Marie Paule, et al.
Publicado: (2017)

Evidence-based medicine and precision medicine: Complementary approaches to clinical decision-making
por: Chow, Ngai, et al.
Publicado: (2018)

Intelligent Clinical Decision Support
por: Pinsky, Michael R., et al.
Publicado: (2022)

Part 6: Essentials of Neonatal–Perinatal Medicine fellowship: program administration
por: Gillam-Krakauer, Maria, et al.
Publicado: (2022)

Honoring antiparasitics: The 2015 Nobel Prize in Physiology or Medicine
por: Chen, Wei-June
Publicado: (2016)

Implementing Genomic Clinical Decision Support for Drug‐Based Precision Medicine
por: Freimuth, RR, et al.
Publicado: (2017)

Should COVID-19 Vaccines Authorized for Emergency Use Be Considered “Essential” Medicines?
por: Smith, Maxwell J., et al.
Publicado: (2021)

Transparent and tough bulk composites inspired by nacre
por: Magrini, Tommaso, et al.
Publicado: (2019)

Inside the security mind: making the tough decisions
por: Day, Kevin
Publicado: (2003)

Tough decisions in pulmonary embolism: thrombolysis or embolectomy?
por: Liew, Alphonsus, et al.
Publicado: (2016)

Lessons learned from Ebola Vaccine R&D during a public health emergency
por: Kieny, Marie-Paule
Publicado: (2018)

Improving Research into Models of Maternity Care to Inform Decision Making
por: de Jonge, Ank, et al.
Publicado: (2016)

Global access to affordable direct oral anticoagulants
por: Neumann, Ignacio, et al.
Publicado: (2021)

How to improve antibiotic awareness campaigns: findings of a WHO global survey
por: Huttner, Benedikt, et al.
Publicado: (2019)

Measuring antibiotic availability and use in 20 low- and middle-income countries
por: Knowles, Rebecca, et al.
Publicado: (2020)

Review of Institute of Medicine and National Research Council Recommendations for One Health Initiative
por: Rubin, Carol, et al.
Publicado: (2013)

Compassionate Leadership: Essential for the Future of Tropical Medicine and Global Health
por: Harrel, Evan, et al.
Publicado: (2021)

The Pharmaceutical Pricing and Reimbursement Information (PPRI) network – a decade of exchange of information and policy research?
por: Vogler, Sabine, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vhi2e0l9b7kvb397019vk44egk